Skip to main content

Advertisement

SpringerLink
Log in

Resolution of Refractory Eosinophilic Esophagitis with the Leukocyte-Trafficking Inhibitor Natalizumab

  • Correspondence
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Grandinetti T, Biedermann L, Bussmann C, Straumann A, Hruz P. Eosinophilic gastroenteritis: clinical manifestation, natural course, and evaluation of treatment with corticosteroids and vedolizumab. Dig Dis Sci. (Epub ahead of print). https://doi.org/10.1007/s10620-019-05617-3.

  2. Cherry LN, Yunker NS, Lambert ER, Vaughan D, Lowe DK. Vedolizumab: an alpha4beta7 integrin antagonist for ulcerative colitis and Crohn’s disease. Ther Adv Chronic Dis. 2015;6:224–233.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Kim HP, Reed CC, Herfarth HH, Dellon ES. Vedolizumab treatment may reduce steroid burden and improve histology in patients with eosinophilic gastroenteritis. Clin Gastroenterol Hepatol. 2018;16:1992–1994.

    Article  PubMed  Google Scholar 

  4. Schoepfer A, Blanchard C, Dawson H, et al. Eosinophilic esophagitis: latest insights from diagnosis to therapy. Ann N Y Acad Sci. 2018;1434:84–93.

    Article  CAS  PubMed  Google Scholar 

  5. Taft TH, Mutlu EA. The potential role of vedolizumab in concomitant eosinophilic esophagitis and Crohn’s disease. Clin Gastroenterol Hepatol. 2018;16:1840–1841.

    Article  PubMed  Google Scholar 

  6. Rice GPA, Hartung H-P, Calabresi PA. Anti-α4 integrin therapy for multiple sclerosis. Mech Ration. 2005;64:1336–1342.

    CAS  Google Scholar 

  7. Tramacere I, Del Giovane C, Salanti G, D’Amico R, Filippini G. Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis. Cochrane Database Syst Rev. 2015;9:CD011381.

    Google Scholar 

  8. MacDonald JK, McDonald JW. Natalizumab for induction of remission in Crohn’s disease. Cochrane Database Syst Rev. 2007;1:CD006097.

    Google Scholar 

  9. Ho PR, Koendgen H, Campbell N, Haddock B, Richman S, Chang I. Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies. Lancet Neurol. 2017;16:925–933.

    Article  CAS  Google Scholar 

  10. Brandt EB, Zimmermann N, Muntel EE, et al. The alpha4beta7-integrin is dynamically expressed on murine eosinophils and involved in eosinophil trafficking to the intestine. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2006;36:543–553.

    Article  CAS  Google Scholar 

  11. Rieder F, Nonevski I, Ma J, et al. T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis. Gastroenterology. 2014;146:1266–1277.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Norfolk and Norwich University Hospital, Norwich, NR4 7UY, UK

    Ian L. P. Beales

Authors
  1. Ian L. P. Beales
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ian L. P. Beales.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Beales, I.L.P. Resolution of Refractory Eosinophilic Esophagitis with the Leukocyte-Trafficking Inhibitor Natalizumab. Dig Dis Sci 64, 2688–2689 (2019). https://doi.org/10.1007/s10620-019-05704-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-019-05704-5

Search

Navigation